MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients

This study has been completed.

Study NCT00078013 Information provided by Mitsubishi Tanabe Pharma Corporation

First Received: February 13, 2004 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2004
Estimated Primary Completion Date:	No date given